Navigation Links
PharmaNet Development Group Clinical Research Experts to Present at Global Professional Meetings in June
Date:6/10/2009

PRINCETON, N.J., June 10 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to innovative pharmaceutical, biotechnology, generic drug and medical device companies, today announced its participation at several international professional meetings during the month of June.

    June 23   45th Drug Information Association (DIA) Annual Meeting
              San Diego, California, Booth 321
              Betty Kuhnert, PhD, MBA, Executive Director, Training Services,
              will chair a session entitled Critical Success Strategies for
              Professional Development and will present "So You Have a New
              Job, Now What? Tactics for Surviving a Job Transition."

    June 24   Phacilitate's Active Immunotherapeutics Forum
              Barcelona, Spain
              Joyce Frey-Vasconcells, PhD, Executive Director, PharmaNet
              Consulting, will make a presentation on "Delivering Strategic
              Solutions to Manufacturing and Product Characterization
              Challenges with Allogeneic Therapies."

              AAPS National Biotechnology Conference
              Seattle, Washington, Booth 305
              Taylor Technology's Robert Dodge, PhD, Laboratory Director,
              Immunochemistry and Cell Biology, Jason Morse, Director,
              Information Technology and Lisa Werdal, Database Systems
              Manager, will be presenting their poster: "Development and
              Implementation of an Information Management System for Tiered
              Immunogenicity Sample Testing and Reporting."

              Robert Dodge, PhD, Marisa Castellana, Research Scientist and
              Dania Yaskanin, Associate Director, Immunochemistry, will also
              present their poster entitled "Optimization of Commercial ELISA
              Kits for the Quantitation of Human Luteinizing Hormone and
              
'/>"/>
SOURCE PharmaNet Development Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. PharmaNet Development Group Gives Notice of Anticipated Fundamental Change and Merger to Holders of Its Convertible Notes
2. PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office
3. An Affiliate of JLL Partners, Inc. Commences Cash Tender Offer to Acquire PharmaNet Development Group, Inc. at $5.00 per Share
4. PharmaNet Development Group Agrees to be Acquired by JLL Partners
5. Abbott & BioGenex Extend the Technology Co-development and Distribution Agreement for Marketing the Xmatrx(R) Advanced Staining Platform for the Automation of FISH, IHC and ISH Molecular Diagnostic Assays
6. Plexus Awarded Development Contract With QIAGEN
7. AFFiRiS AG: Atherosclerosis Vaccine Development Receives EU Support
8. Microbia, Inc. Names Alex Chu as Vice President of Process Development
9. China Sky One Medical, Inc. Signs Agreement with Taiwan Golden Biotechnology Corp. on Development of New Anti-Cancer Drug
10. Dr. Chris Huber Joins Asymchem Laboratories Inc. as Director of Chemical Development
11. Cord Blood America to Hold Conference Call on Thursday May 21st at 11 a.m. Eastern Time to Discuss 2009 First Quarter Results and Corporate Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... April 1, 2015  Spherix Incorporated (Nasdaq: ... the fostering and monetization of intellectual property, today ... held full service global investment bank specializing in ... industry note featuring Spherix. The report, ... Senior Analyst at Chardan, was published on March ...
(Date:4/1/2015)... National recruitment firm Slone Partners is pleased ... of Sales at Optimal Medicine, an international digital health ... brings over 20 years experience in healthcare information technology ... including Dell Services Healthcare, Medsphere Systems and McKesson. ... for accomplishing the goals Optimal Medicine had for this ...
(Date:3/31/2015)... VANCOUVER , March 31, 2015  /PRNewswire/ - ESSA ... today that it has filed with the Food and ... Drug ("IND") application related to the Company,s proposed clinical ... the IND application is required in order for ESSA ... The IND application is a complete ...
(Date:3/31/2015)... March 31, 2015  Sonoa Health, a health tech ... has developed a world-first consumer health portal, Health&, which ... wearable devices and more. Today, the Company ... its CEO, who brings to the table more than ... has included working closely with the biggest names in ...
Breaking Biology Technology:Chardan Capital Issues Industry Note Covering Spherix 2Chardan Capital Issues Industry Note Covering Spherix 3Slone Partners Fills Head of Sales at Optimal Medicine 2ESSA Pharma Inc. Announces Filing of Investigational New Drug Application for EPI-506 2ESSA Pharma Inc. Announces Filing of Investigational New Drug Application for EPI-506 3ESSA Pharma Inc. Announces Filing of Investigational New Drug Application for EPI-506 4Investment Banker Appointed CEO of Australian Health Tech Start-Up 2Investment Banker Appointed CEO of Australian Health Tech Start-Up 3
... -- increase of 110% from prior year , , ... KNSY ), a leading medical technology company that provides innovative solutions ... the results for its second quarter and first six months of ... Record EPS of $0.44, representing ...
... The Brazilian Ministry of Agriculture has authorized Dow AgroSciences ... Insect Protection technology. This authorization was given ... Dow AgroSciences also announced that it plans to be ... of corn hybrids with this technology in the future."This ...
... The Binding Site Limited,("The Binding Site" or the ... the publication of the first,international guidelines recommending first-line ... multiple myeloma, a cancer of cells in the ... The guidelines were written on ...
Cached Biology Technology:Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 2Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 3Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 4Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 5Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 6Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 7Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 8Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 9Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 10Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 11Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 12Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 13Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 14Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 15Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 16Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 17Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results 18Dow AgroSciences Receives Approval for Cultivation of HERCULEX(R) I Corn in Brazil 2International Guidelines for First-Line use of Freelite(TM) in Diagnosis and Management of Multiple Myeloma to be Published in "Leukemia" 2International Guidelines for First-Line use of Freelite(TM) in Diagnosis and Management of Multiple Myeloma to be Published in "Leukemia" 3International Guidelines for First-Line use of Freelite(TM) in Diagnosis and Management of Multiple Myeloma to be Published in "Leukemia" 4International Guidelines for First-Line use of Freelite(TM) in Diagnosis and Management of Multiple Myeloma to be Published in "Leukemia" 5International Guidelines for First-Line use of Freelite(TM) in Diagnosis and Management of Multiple Myeloma to be Published in "Leukemia" 6International Guidelines for First-Line use of Freelite(TM) in Diagnosis and Management of Multiple Myeloma to be Published in "Leukemia" 7
(Date:3/23/2015)... , March 23, 2015 SoundView Technology Group issues ... (NASDAQ: NXTD ) Wocket smart wallet. SoundView was one of ... on their experience with the Wocket in multiple scenarios and ... Whole Foods and other retailers, making both debit and credit ... also says, "If the company meets their plans in ...
(Date:3/23/2015)... Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company"), a ... announces its biometric payment technology, the Wocket® smart wallet, will ... 30 th . The new 30 ... markets. Gino Pereira , ... ad campaign following the recent initial shipment of Wocket smart ...
(Date:3/20/2015)... OXFORD, Conn. , March 20, 2015 ... "Company"), a biometric authentication company focused on the growing ... Wocket® smart wallet is one of the products featured ... today, March 20th at 11:00 PM EST on the ... travels to Las Vegas , site ...
Breaking Biology News(10 mins):Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3
... their way, cheetahs, lions, elephants, camels and other large wild ... "If we only have 10 minutes to present this idea, ... and evolutionary biology at Cornell. "But if people hear the ... much as we have. Right now, we are investing all ...
... A team of engineers from Washington University in St. ... removed bioaerosols -- airborne biological particulate matter -- from ... new generation of hybrid filters. , The bioaerosols identified ... lifeguards who had become ill with hypersensitivity pneumonitis, a ...
... a defensive, protective reaction. This ancestral and automatic behavior ... predator. A new study published in Psychophysiology finds that ... a threat. The mere picture of an injured or ... images, the study's participants froze as their heart rate ...
Cached Biology News:Proposal would allow wild animals to roam North America 2Proposal would allow wild animals to roam North America 3Device traps, disables harmful bacteria 2When in danger humans are similar to a deer in the headlights 2
... Consists of the LVF-HL, LVF-CUVADPT, FHS-LVF, and ... high-pass and low-pass Linear Variable Filters to ... an adjustable center wavelength and adjustable bandpass. ... (~90%) and blocking band (99.8%). These ...
... of the LVF-UV-HL, LVF-CUV-ADP, FHS-LVF and CVD-Diffuse ... low-pass Linear Variable Filters to create the ... center wavelength and adjustable bandpass. Each filter ... blocking band (99.8%). These filters -- ...
, Premium quality synthesis and purification , You provide the sequence, we'll do the rest , Rigorous quality control , Your choice of purification method, amount and format , Available annealed...
Request Info...
Biology Products: